European Capital Assembly
1 Birdcage Walk, Westminster, London SW1H 9JJ, UK
The European Capital Assembly will take place in London on 11 March 2020. The event will be an informative conference with speakers from all facets of the CBD, medical and wellbeing industries.
The event will take place at One Birdcage Walk (Lecture Theatre), Westminster, London, SW1H 9JJ. A detailed agenda may be found at www.europeancapitalassembly.com.
Arrival & Coffee/Networking
Opening Remarks and State of the Industry
Key Steps to get Funding from an Investor
Private vs Public Markets in Cannabis
Differentiation in the Consumer Space
How to prepare for the International Expansion?
FSA has Spoken, Who will Survive?
What is Next in Medical Cannabis?
Drinks Afterparty at Vintry & Mercer
Alexej Pikovsky, CEO & Co-Founder, Alphagreen Group
Alexej and his co-founders saw the need to help European customers access the best products in wellness and medical cannabis. Alphagreen Group operates a curated marketplace in the UK and separately imports and distributes medical cannabis to pharmacies in Germany.
Prior to Alphagreen, Alexej has been working as an investor for a large-cap private equity fund and a family office where he ran the venture capital operations. He gained operational and board-level experience working closely with Compo Expert, the largest European specialty fertiliser business, as well as leading their trade sale. Alexej started his career in M&A at Nomura.
Alexej holds a Masters from Imperial College London and is a Fellow of the German National Academic Foundation.
Stephen Murphy, Managing Director & Co-Founder of Prohibition Partners (NOBL Group)
As a cannabis specialist focused on developing the legal European cannabis industry, Stephen is a co-founder of ECH, Europe's cannabis investment group, and Cannabis Europa, Europe’s premier medical cannabis conference. With a background in technology, digital media and corporate finance, Stephen works with investors, entrepreneurs and regulators to identify, qualify and maximise the opportunities in this emerging frontier
Camilla Hansson, Founder of Camilla Organics
Camilla was inspired to start the company after having struggled from a condition called endometriosis, causing painful menstrual cramps. She found the relief she was looking for in CBD oil and wanted to share its benefits with other women. This led Camilla to create her own premium quality CBD products which are especially formulated for women.She has previously studied Naturopathy and Nutrition at CNM London with a focus on women’s natural health. Prior to entering the CBD industry Camilla won the Miss Sweden competition in 2014 and has worked as an international model.
Hannah Skingle, COO, Dragonfly Biosciences Ltd
Hannah’s progression at Dragonfly from Business Development to COO within a year is a testament to her drive. Making her mark early on this blossoming industry, she has played an integral role in growing Dragonfly from the backend over the past three years. She successfully launched the DragonflyCBD brand as the first CBD product into Boots, which had a launch timeline of just 6 weeks, defying the norms of the health and wellness space. In addition, DragonflyCBD was the first CBD product to launch in Tesco and has established DragonflyCBD as a leading brand in the fast-growing complex CBD category. Hannah offers thought leadership at a number of cannabis events such as The Grocer, CBD Summit and Cannabis Europa. Hannah was schooled in the world of business, she topped the Management Tripos at King’s College London and holds a Master’s in Management from LSE. During the latter, her final project focused in on innovative industries and how diversity is key to encouraging their development. She’s put her thesis to the test at Dragonfly by building a fresh-faced team in their early 20s.
Scott Kelly, Director and Co-Founder of Wetherby Growth PLC
Scott Kelly is a Director and Co-Founder of Wetherby Growth PLC, an emerging investment firm in London focused on funding opportunities in the Global Cannabis Industry. Wetherby makes equity and debt investments and co-invests alongside industry leaders.
Scott served as an Executive Chair of Newstrike Brands (HIP.V), where he led a privately-held Canadian licensed producer of cannabis through a highly successful RTO in 2017 and oversaw a series of financings totaling over C$150 million in 2018. In 2019, Newstrike was acquired by a top 5 TSX listed Cannabis Company listed on the TSX and NYSE.
Scott is a serial entrepreneur who also worked at the TMX Group, the parent company for the Toronto Stock Exchange and TSX Venture Exchange, acted as a director and investor in many listed companies over his career, and has sat on various Audit, Compensation and Governance Committees. Scott holds a BA from Queen’s University, Canada, and further certification from the Venture Capital Executive Program at University of California, Berkeley, Haas School of Business.
Crispin Blunt, Member of the Parliament
Crispin was elected MP for Reigate in 1997 having formerly served as an army officer.
In Parliament, Crispin has served in the Shadow Cabinet with briefs including trade and energy and security and counter-terrorism. He has served as both Minister for Prisons and as Chairman of the Foreign Affairs Committee.
Crispin is currently the Chair of the All-Party Parliamentary Group (APPG) on Global LGBT Rights, co-chair of the APPG for Humanism and co-Chair of the APPG on Drug Policy Reform. He is the Conservative Middle East Council’s Vice-Chair.
In January 2019 Crispin set up and launched the Conservative Drug Policy Reform Group whose objective is to promote evidence-based drug policy reform on the centre right. He is currently the Group’s unremunerated Chair and Chief Executive Officer.
Olivia Ferdi, Co-Founder of Trip Drinks
Olivia trained as a solicitor in the City, and began using CBD to help with anxiety. Her husband Daniel had recommended CBD after finding immense benefits with recovery from knee surgery in 2018. Olivia wanted a CBD product she could use on the go, to be included in her active every day routine and with branding that wouldn’t look out of place on her work desk.
TRIP was created by Daniel and Olivia in August 2019 as a unique answer to the demand for millennial friendly products. TRIP has quickly built an incredibly strong following in the wellness and lifestyle space - available in premium destinations such as Selfridges, Harvey Nichols, Equinox gyms and 5 Hertford Street.
Frederick Hendriksen, VP of International Sales & Business Development, Mile High Labs
Frederik Hendriksen is VP of International Sales & Business Development at Mile High Labs. He grew up in a small town in north western Denmark, moving to Copenhagen Business School for his bachelor’s and master’s degrees. During this time he took the opportunity to work in Japan, China, Zambia and London, where he settled in 2014. He joined Morgan Stanley doing Investment Banking, fast tracking to Vice President and being selected for the most prestigious talent programme MS offers.Fred resigned from his banking job in early 2019 to join Mile High Labs, the world's leading CBD ingredient manufacturer, building and managing sales for all non-US markets. The company is leading the way in ensuring compliance within the current regulatory framework. MHL is also investing heavily in R&D, working closely with a range of top universities to ensure the highest standards of consumer safety and develop a range of new products.
Dr Tasmina Goraya, Partner at Taylor Wessing, Life Sciences Group
Tasmina is partner in the Patents team of Taylor Wessing and a member of the firm's Life Sciences Group. She specialises in three areas with a particular focus on life sciences: regulatory compliance; patent and commercial disputes with a particular focus on arbitrations; and transactional IP (including IP and regulatory support on M&As and investments). Her regulatory work covers a wide spectrum of regulatory and compliance issues in the pharmaceutical, medical device and healthcare sectors.
Tasmina has a degree in Toxicology & Pharmacology from London University and a PhD in Pharmacology from Cambridge University and was previously a post-doctoral research associate in academia prior to moving into law. She qualified as a solicitor (England & Wales) in 2011 and has a Diploma in Intellectual Property Law and Practice from Oxford University.
Bekkozha Muslimov, Partner at Leafy Tunnel
Bek is a Partner and member of the founding team at Leafy Tunnel, an investment firm dedicated to investing in early stage companies focused on mental health and palliative care. His recent investments at Leafy Tunnel includes Wundr Co.(European cannabis company), ATAI Life Sciences(biotech platform curing mental health disorders) andSynthesis Institute(medically supervised retreats).Prior to Leafy Tunnel Bek has beenan InvestmentDirector at Blue Wire Capitaland has been investing in European technology and life science companies for the past 7 years. While at Blue Wire he has led investments in technology companies Monzo, Superawesome, Homehero, Ocean Harvest, Ihateironing.Bek is an MBA graduate of London Business School.
Niel Marotta, President & CEO of Indiva
President & CEO of Indiva, a publicly listed Cannabis extraction and manufacturing company in Ontario, Canada.Niel was a top performing fund manager at a prominent US firm, where he managed a portfolio of over $1 Billion across several industries. He also served as Vice President for a TSX listed natural resource focused company. Subsequently, Niel worked as an investment banker, and has been involved in financings and M&A transactions exceeding $1 Billion. Niel is a graduate of McGill University’s commerce program.
Laurène Tran, Director
Laurène Tran works at the intersection of cannabis policies and strategy in Europe.
As the director of ACTIVE, a pan-European association, she led 2 reports - CBD in France and CBD in Europe with the contributions of several experts and officials.
She organized, "Cannabis Renaissance" the fist major conference on cannabis at the European Parliament in Brussels and subsequently launched, Shift Europe, an online publication to sketch the path to build a common regulatory framework for medical cannabis in Europe.
Laurène was an adjunct lecturer at Sciences Po School of Public Affairs in tech & policy; and graduated from ESSEC Business School.
Toby Gordon-Smith, CEO and co-founder of Grass & Co.
Toby has been the driving force behind the Grass & Co brand, looking to shape and deliver a trusted British brand that combines the highest quality, naturally grown CBD with other botanical ingredients. Grass & Co is listed in Selfridges, Goodbody Wellness and recently launched into Boots and Ocado. Toby previously spent 7 years as Strategy Director for Glanbia’s EMEA Performance Nutrition division, and prior to this worked at Diageo and Bain & Co. He has a particular interest in the anxiety and pain-relieving qualities of CBD, having experienced a life-changing paragliding injury in 2011 which has left him with chronic pain and sleep problems.
Markus Hoffman, Co-founder of Sky Labs Singapore
A lawyer by training, Markus has a background in the private equity sector and has been active in the medical cannabis industry for over 5 years. Most recently he was on the founding team of Jacana, a vertically integrated manufacturer of medical cannabis products. Previously, Markus led the only outside investment in the renowned Dutch manufacturer Bedrocan International by a group of family offices.
At Sky Labs, Markus is focused on building a one stop solution for all the product development, testing and contract research needs of companies wishing to tap into the rapidly growing cannabis market.
Additionally, Sky Labs operates an in-house R&D program, led by Prof. David Meiri, one of the leading minds in cannabinoid science. Sky Labs researches, develops and innovates to deliver novel cannabinoid-based medicines for patients in Asia and across the World.
Josh Levy, CEO of KXC
The emerging European adult-use market faces challenges quite distinct from those of the medical sector. Through its fully owned subsidiaries, KXC provides support to global and domestic cannabis brands across marketing (Toniqly), online advertising (Bloom IQ) and wholesale and distribution services (Bloom Distribution).
Prior to KXC, Josh was a co-founder of UK based medical cannabis business Golders Hill (Acquired by Greenstar Global Inc and now trading as Wundr Co). Before entering the cannabis sector, Josh was a venture and growth capital investor, initially as part of the founding team of Mercia Asset Management PLC (AIM: MERC) & latterly as an investment Executive at Mobeus Equity Partners LLP.
Richard Skaife, CEO and Co-Founder of Cobidol Group
Serving the digital CBD industry with a platform for growth, payments, trust and scale.
Partner at The Cannabis Fund. A Malta HQ’d fund focused on early stage legal cannabis and hemp investing across Eurasian markets.
Chair at Grow Media Group who’s assets include; The Cannabis Conversation, The Green Light and CannaInvestor Europe & Asia.
A twenty year veteran of the tech and venture industry. A pioneer in digital lending with Pollen VC and mental wellness with Digipill.
Andrew Rosen, Head of Global Business Development for Cannatrek
Andrew Rosen is the Head of Global Business Development for Cannatrek, a medical cannabis company in Australia focused on superior cultivation and medical product development. He has assisted numerous companies in the cannabis industry to expand and strategize activities in international markets. He also holds a position as the Director of Strategic Partnerships for Cannamerx, the leading commodities exchange in the Cannabis and Hemp industry with over 250 members globally.
Isaac Davidson, Founder of Cannacares
Isaac’s principal responsibility includes strategy, vision and marketing. Prior to founding Cannacares in early 2019, Isaac held various managerial positions across the recruitment and property sectors. He had been Managing Director of Thomas Fowley (UK-based quantitative research head-hunter firm) and prior to that, Consultant at GLPG (land, development and investment agency focusing on London and South East England). Isaac studied Real Estate Management at Westminster University.
Lukas Hirsch, VP Business Development of Equinox International
Lukas Hirsch is VP Business Development of Equinox International Ltd, one of the UK’s leading cannabis companies. Lukas is focused on developing products across numerous categories, brands and geographies in OTC and medicinal cannabis markets. Prior to joining Equinox, Lukas spent over 5 years growing a leading international family office and property company, preceded by 5 years at Standard Bank.
George Thomas, Managing Director of Goodbody Botanicals, Sativa Group
George is a successful entrepreneur with a proven track record in new and exciting markets. He has been involved in the mobile app development sector and more recently, a co-founder and shareholder of George Banco Ltd, an unsecured guarantor lending business started in 2013 which grew to a core size of 70 people with a loan book of £34 million. The company later sold in 2017 to a public company called NSF PLC. With a penetrative eye for emerging sectors and with experience in markets ahead of the ‘green-wave’ like Canada and the USA, the UK Cannabis market was an opportunity he felt couldn’t be missed.
Tony Fowler, Founder of O'Shaughnessy Drink Company
Tony is recognized as creating the first Canna Drinks in the UK after setting up the O'Shaughnessy Drink Company in 2017 when he saw the gap in the Market for All-Natural canna drinks. The company was named after the William Brooke O'Shaughnessy the cannabis pioneer who introduced Cannabis to the west in 1839 after his ground breaking work on the plant.
The Company mantra is 'No Nasties' as they believe passionately in creating eco-friendly, all-natural drinks. They are about to launch their first RTDs which once again will push the boundaries of Canna Drinks here in the UK. Tony is also an activist in the campaign to change the rules here in the UK for farmers to grow and use the whole plant.
Oliver Zugel, Founder and CEO - FoliuMed
Oliver Zugel is the founder and CEO of FoliuMed, a producer of pharma-gradeingredients and extracts for the European health & wellness markets. FoliuMed growsmedicinal cannabis under ideal climatic conditions in Colombia which then getspurified and processed in a GMP certified pharma facility. This allows FoliuMed tooffer safe, EU-compliant input materials for CBD manufacturers at highly competitiverates.Mr. Zugel is a serial cannabis entrepreneur who operates medical and adult-usebusinesses in Europe, the USA and Latinamerica. His multi-jurisdictional experience,strategic insight and prior leadership roles in highly regulated industries have made hima sought after speaker on the international cannabis conference circuit. He holds a FirstClass Degree from the London School of Economics where he studied as a KingEdward VII scholar and is a former partner of Harvard Strategy Guru Michael Porter.
This listing has no upcoming events